Three publicly traded Chinese drugmakers which count global banks such as UBS and HSBC as investors have used parts of endangered animals as ingredients in their products, an environmental group said.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in